MSBMESOBLAST LIMITEDMarket sensitive

Pivotal Phase 3 Trial in CLBP Achieves 300 Treated Patients

Date and time
Announcement type
Company Update
Show details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASXOpen original PDFMSB announcement history

Recent MSB announcements